Pressure on insulin manufacturers in the US has been building
Novo Nordisk to provide cheaper insulin amid criticismNovo Nordisk will offer a generic and a discount cash card.
> Read more
News and insights brought to you by the International Diabetes Federation
Apply filters
A carefully selected mix of IDF announcements and global news stories summarised for you. Our selections are geographically based from IDF regions and thematic topics including advocacy, economics, science and technology, and more. Get informed!
T helper cells could serve as a target for immunotherapy in type 1 diabetes
T helper cells associated with onset of type 1 diabetesNew study results suggest that findings have the potential to serve as a target for immunotherapy in type 1 diabetes.
> Read more-
A pilot project for diabetes care in Pakistan, “Insulin for All”, will provide insulin to children living with type 1 diabetes in three districts of the Punjab. -
The IDF SEA region includes seven countries and territories, each with unique socioeconomic and healthcare challenges. However, one common thread is the rising diabetes impact.
-
From revelations in treatment options to the likelihood of inheriting type 1 diabetes, the presentations at EASD 2024 will potentially shape the future of diabetes management and prevention.
Do you like what you see?
Subscribe to our e-alerts.
Subscribe to our e-alerts.